Article PDF
References
Stefan Y et al. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982;31:694–700.
Tarn AC, et al. Type 1 (insulin-dependent) diabetes: a disease of slow clinical onset? BMJ 1987;294:342–5.
Foulis AK, et al. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986;29:267–74.
Gepts W . Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965;14:619–33.
Bottazzo GF, et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353–60.
Foulis AK, Jackson R, Farquharson MA . The pancreas in idiopathic Addison's disease: a search for a prediabetic pancreas. Histopathology 1988;12:481–90.
Foulis AK, McGill M, Farquharson MA . Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes and interferon-gamma containing cells. J Pathol 1991;165:97–103.
Bottazzo GF . Beta-cell damage in diabetic insulitis: are we approaching a solution? Diabetologia 1984;26:241–9.
Wolf E, Spencer KM, Cudworth AG . The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 1983;24:224–30.
Bottazzo GF, et al. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;2:1115–8.
Foulis AK, Farquharson MA . Aberrant expression of HLA-DR antigens by insulin containing beta cells in recent onset type 1 (insulin-dependent) diabetes mellitus. Diabetes 1986;35:1215–24.
Foulis AK, Farquharson MA, Hardman R . Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabe-tologia 1987;30:333–43.
Hanafusa T, et al. Examination of islets in the pancreas biopsy specimens from newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia 1990;33:105–11.
Foulis AK, Farquharson MA, Meager A . Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987;2:1423–7.
Banatvala JE, et al. Coxsackie B, mumps, rubella, and cyto-megalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985;1:1409–12.
Mueller-Eckhardt G, et al. Complications of mumps infection, islet-cell antibodies, and HLA. Immunobiology 1984;167:338–44.
Forrest JM, Menser MA, Burgess JA . High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971;2:332–4.
Foulis AK . Lawrence Lecture: In type 1 diabetes, does a non-cytopathic viral infection of insulin-secreting B-cells initiate the disease process leading to their autoimmune destruction? Diabetic Med 1989;6:666–74.
Clark A, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988;9:151–9.
Westermark P, et al. Amyloid fibrils in human insulinoma and islets of Langerhans in the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881–5.
Clark A, et al. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type 2 diabetes. Lancet 1987;l:231–4.
Ebert R, Creutzfeldt W . Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steator-rhoea following enzyme substitution. Diabetologia 1980;19:198–204.
Rahier J, et al The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia 1987;30:5–12.